RANDHAWA SIMRAT (EVP, Head of R&D) sold 33.83K shares of DIANTHUS THERAPEUTICS, INC. /DE/ on the open market
Open‑market sale worth $2.76M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+8K
Price / share
$8.44
Trade value
$67.50K
% of position
Common Stock
Shares
+5K
Price / share
$17.88
Trade value
$89.40K
% of position
Common Stock
Shares
+8.33K
Price / share
$21.77
Trade value
$181.39K
% of position
Common Stock
Shares
+12.50K
Price / share
$22.07
Trade value
$275.88K
% of position
Common Stock
Shares
−33.83K
Price / share
$81.48
Trade value
$2.76M
% of position
Net shares
+0.00
Net value
-$2.14M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2026 | M · Option Exercise | +8K | $8.44 | $67.50K | New position | 0.00 | 8K |
| Common Stock Direct | 3/12/2026 | M · Option Exercise | +5K | $17.88 | $89.40K | 62.5% | 8K | 13K |
| Common Stock Direct | 3/12/2026 | M · Option Exercise | +8.33K | $21.77 | $181.39K | 64.1% | 13K | 21.33K |
| Common Stock Direct | 3/12/2026 | M · Option Exercise | +12.50K | $22.07 | $275.88K | 58.6% | 21.33K | 33.83K |
| Common Stock Direct | 3/12/2026 | S · Sale | −33.83K | $81.48 | $2.76M | New position | 33.83K | 0.00 |
| Total | +0.00 | -$2.14M | ||||||
Stock Option (Right to Buy)
Common Stock
8K shares
Shares
−8K
Strike price
8.44
Held after
4K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
5K shares
Shares
−5K
Strike price
17.88
Held after
71.18K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
8.33K shares
Shares
−8.33K
Strike price
21.77
Held after
54.17K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
12.50K shares
Shares
−12.50K
Strike price
22.07
Held after
106.25K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8K shares | 3/12/2026 | M · Option Exercise | −8K | 8.44 | — | 4K |
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 3/12/2026 | M · Option Exercise | −5K | 17.88 | — | 71.18K |
| Stock Option (Right to Buy) Direct | Common Stock8.33K shares | 3/12/2026 | M · Option Exercise | −8.33K | 21.77 | — | 54.17K |
| Stock Option (Right to Buy) Direct | Common Stock12.50K shares | 3/12/2026 | M · Option Exercise | −12.50K | 22.07 | — | 106.25K |